S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:ATEC

Alphatec (ATEC) Stock Forecast, Price & News

$15.30
+0.05 (+0.33%)
(As of 05:11 PM ET)
Compare
Today's Range
$14.99
$15.55
50-Day Range
$14.32
$16.38
52-Week Range
$5.73
$17.13
Volume
884,820 shs
Average Volume
1.01 million shs
Market Capitalization
$1.81 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.25

Alphatec MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
6.6% Upside
$16.25 Price Target
Short Interest
Bearish
10.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
0.82mentions of Alphatec in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$988.18 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.23) to ($0.90) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars

Medical Sector

700th out of 981 stocks

Surgical & Medical Instruments Industry

67th out of 98 stocks


ATEC stock logo

About Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Stock News Headlines

“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
Alphatec (NASDAQ:ATEC) Upgraded at StockNews.com
Where Alphatec Holdings Stands With Analysts
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin
$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.
StockNews.com Lowers Alphatec (NASDAQ:ATEC) to Sell
Alphatec: A Balancing Act
ATEC Reports First Quarter 2023 Financial Results
Alphatec (ATEC) Set to Announce Earnings on Thursday
Alphatec (NASDAQ:ATEC) Sees Strong Trading Volume
Alphatec Holdings (ATEC) Receives a Buy from Needham
See More Headlines

ATEC Price History

ATEC Company Calendar

Last Earnings
11/04/2021
Today
6/08/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ATEC
CUSIP
02081G10
Employees
561
Year Founded
1990

Price Target and Rating

Average Stock Price Forecast
$16.25
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$9.50
Forecasted Upside/Downside
+6.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-152,150,000.00
Pretax Margin
-39.28%

Debt

Sales & Book Value

Annual Sales
$350.87 million
Book Value
($0.35) per share

Miscellaneous

Free Float
83,991,000
Market Cap
$1.81 billion
Optionable
Not Optionable
Beta
1.25

Social Links


Key Executives

  • Patrick S. MilesPatrick S. Miles
    Chairman, President, CEO & COO
  • J. Todd Koning
    Chief Financial Officer & Executive Vice President
  • Scott LishScott Lish
    Senior Vice President-Research & Development
  • Kelli M. Howell
    Executive Vice President-Clinical Strategies
  • Luiz Pimenta
    Chief Medical Officer













ATEC Stock - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings
or view top-rated stocks.

What is Alphatec's stock price forecast for 2023?

6 brokerages have issued 12 month target prices for Alphatec's shares. Their ATEC share price forecasts range from $9.50 to $20.00. On average, they anticipate the company's stock price to reach $16.25 in the next year. This suggests a possible upside of 6.2% from the stock's current price.
View analysts price targets for ATEC
or view top-rated stocks among Wall Street analysts.

How have ATEC shares performed in 2023?

Alphatec's stock was trading at $12.35 at the beginning of 2023. Since then, ATEC shares have increased by 23.9% and is now trading at $15.30.
View the best growth stocks for 2023 here
.

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our ATEC earnings forecast
.

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) issued its earnings results on Thursday, November, 4th. The medical technology company reported ($0.43) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by $0.20. The medical technology company earned $62.88 million during the quarter, compared to analysts' expectations of $61.43 million. Alphatec had a negative trailing twelve-month return on equity of 575.45% and a negative net margin of 39.28%. During the same quarter last year, the business earned ($0.18) earnings per share.

What guidance has Alphatec issued on next quarter's earnings?

Alphatec updated its first quarter 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $108.00 million-$109.50 million, compared to the consensus revenue estimate of $101.59 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?
What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include First Light Asset Management LLC (2.48%), Next Century Growth Investors LLC (1.78%), State Street Corp (1.62%), Cerity Partners LLC (1.57%), JPMorgan Chase & Co. (1.53%) and Geode Capital Management LLC (1.23%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jeffrey G Black, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal and Scott Lish.
View institutional ownership trends
.

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $15.30.

How much money does Alphatec make?

Alphatec (NASDAQ:ATEC) has a market capitalization of $1.81 billion and generates $350.87 million in revenue each year. The medical technology company earns $-152,150,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Alphatec have?

The company employs 561 workers across the globe.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356.

This page (NASDAQ:ATEC) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -